MORGAN STANLEY PLC/CALL/ENTEGRIS/130/0.1/20.09.24 Stock

Warrant

DE000ME9GFN9

Real-time Bid/Ask 05:53:44 2024-06-04 EDT
0.82 EUR / 0.93 EUR +8.02% Intraday chart for MORGAN STANLEY PLC/CALL/ENTEGRIS/130/0.1/20.09.24
Current month-3.57%
1 month-44.14%
Date Price Change
24-06-03 0.81 -3.57%
24-05-31 0.84 -23.64%
24-05-30 1.1 +4.76%
24-05-29 1.05 -13.22%
24-05-28 1.21 0.00%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 12:38 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ENTEGRIS, INC.
Issuer Morgan Stanley
WKN ME9GFN
ISINDE000ME9GFN9
Date issued 2024-03-01
Strike 130 $
Maturity 2024-09-20 (109 Days)
Parity 10 : 1
Emission price 1.95
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.53
Lowest since issue 0.81
Spread 0.11
Spread %11.83%

Company Profile

Entegris, Inc. is a supplier of advanced materials and process solutions for the semiconductor and other high technology industries (high-tech). The Company's segments include Materials Solutions (MS), Microcontamination Control (MC) and Advanced Materials Handling (AMH). The MS segment provides advanced consumable materials, such as chemical mechanical planarization (CMP) slurries and pads, deposition materials, process chemistries and gases, formulated cleans, etchants and other specialty materials. The MC segment is engaged in filtering and purifying critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-tech industries. The AMH segment protects critical materials during manufacturing, transportation, and storage; including products that monitor, protect, transport and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor, life sciences and other high-tech industries.
Sector
-
More about the company

Ratings for Entegris, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Entegris, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
126.1 USD
Average target price
145.3 USD
Spread / Average Target
+15.27%
Consensus